Superdisintegrants Market Research Report-Global Forecast till 2027

Superdisintegrants Market Research Report by Type (Synthetic Superdisintegrants, Natural Superdisintegrants, and Others), Formulation (Tablets, Capsules), Therapeutic Area (Neurological Diseases, Gastrointestinal Diseases, Oncology, and Others), and Region (America, Europe, APAC, Middle East & Africa)–Global Forecast to 2027

ID: MRFR/Pharma/5200-HCR | February 2021 | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Snapshot


The Global Superdisintegrants Market is anticipted to grow at an optimistic CAGR of 7.9% during the forecast period from 2018 to 2023. Disintegrants are substances which are included in drug formula to allow proper disintegration of the capsule or tablet into easily dissolvable particles. This plays a vital function in the fast absorption of medicine which increases its efficacy. Superdisintegrants are slightly modified disintegrants which offer higher efficiency than their traditional counterparts. Observed to have valued at USD 371 Mn in 2017, the global superdisintegrants market is poised to appreciate to reach an estimated value of USD 576.2 Mn by the end of 2023.


The pharmaceutical industry is growing at breakneck speed, becoming a significant part of the healthcare sector. This is primarily due to rising populations of both geriatric patients and pediatric patients. Superdisintegrants are helpful for treatment of patients from this demographic as these tablets are easier to swallow. The growth of these demographics is expected to drive market growth. Moreover, generic drugs are in high demand as patents have begun to run out on several popular drug brands, thus opening up the pharmaceutical industry for increased entry of competition and a rise in the manufacturing of generic drugs, thus driving demand for superdisintegrants.


Emerging markets represent significant opportunity as the healthcare sectors in these regions are growing at a swift pace. Moreover, large patient pools are in these countries are expected to increase demand for fast-acting medication. Market players are likely to establish themselves in the region in an effort to leverage the opportunities available in emerging economies.


Report Overview


MRFR's global superdisintegrants market report contains an entire historical analysis along with current trends to assemble a panoramic view of the market. Drivers, restraints, threats, and opportunities have been expounded in the report along with projections for the future of the market over the forecast period from 2018 to 2023. All parameters relevant to the global superdisintegrants market have been taken into account including the various parts of the market which have been segmented on the basis of types, formulation, therapeutic area, and region. Moreover, various key players operating in the market's competitive landscape have been profiled to provide an impact analysis of various vital growth strategies.


Players Covered


Prominent market participants that have been profiled in the report include Asahi Kasei Corporation, DFE Pharma, JRS Pharma, Corel Pharma Chem, Ashland Global Holdings Inc., BASF SE, Roquette Freres, DowDuPont Inc., Merck KGaA, and Avantor Performance Materials, LLC


Research Methodology


Market Research Future's market report on the global surface disinfectant market has employed various proprietary research methods to ascertain the forecast of the market. Primary data sources such as personal one-on-one interviews with marketing directors, and other important executives, thus providing a deeper insight into industry performance and expectations of the market. Meanwhile, secondary sources of data which refer to both internal and external sources such as customer feedback, analysis of marketing activities, industry publications, annual reports, and others are useful for a full commercial study of the global surface disinfectant market. Moreover, MRFR's data analysts use both top-down and bottom-up approaches for the estimation and validation of market size. All data is processed, analyzed and consolidated into brief palatable reports which include intelligent observations regarding various important market factors. 


Segmentation


Type



  • Synthetic Superdisintegrants

  • Natural Superdisintegrants

  • Other Superdisintegrants


Formulation



  • Tablets

  • Capsules


Therapeutic Area



  • Neurological Diseases

  • Gastrointestinal Diseases

  • Oncology

  • Inflammatory Diseases

  • Cardiovascular Diseases

  • Hematological Diseases

  • Infectious Diseases


Region



  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa



Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction


2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Superdisintegrants Market, by Type

6.1 Introduction

6.2 Synthetic Superdisintegrants

6.2.1 Crospovidone

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.2 Modified Starch

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.3 Modified Cellulose

6.2.3.1 Croscarmellose Sodium

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.3.2 Low-Substituted Hydroxypropyl Cellulose

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.4 Calcium Silicates

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.5 Ion Exchange Resins

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3 Natural Superdisintegrants

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4 Other Superdisintegrants

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 7. Global Superdisintegrants Market, by Formulation

7.1 Tablets

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.2 Capsules

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 8. Global Superdisintegrants Market, By Therapeutic Area

8.1 Neurological Diseases

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.2 Gastrointestinal Diseases

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3 Oncology

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4 Inflammatory Diseases

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.5 Infectious Diseases

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.6 Cardiovascular Diseases

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.7 Hematological Diseases

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 9. Global Superdisintegrants Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles


11.1 BASF SE

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Ashland Global Holdings Inc.

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 DowDuPont Inc.

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Roquette Freres

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 DFE Pharma

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 JRS Pharma

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Asahi Kasei Corporation

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Merck KGaA

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Corel Pharma Chem

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Avantor Performance Materials, LLC

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Superdisintegrants Market Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Superdisintegrants Market Synopsis, 2020–2027

Table 2 Global Superdisintegrants Market Estimates and Forecast, 2020–2027 (USD Million)

Table 3 Global Superdisintegrants Market, by Region, 2020–2027 (USD Million)

Table 4 Global Superdisintegrants Market, by Type, 2020–2027 (USD Million)

Table 5 Global Superdisintegrants, by Formulation, 2020–2027 (USD Million)

Table 6 Global Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)

Table 7 North America: Superdisintegrants Market, by Type, 2020–2027 (USD Million)

Table 8 North America: Superdisintegrants, by Formulation, 2020–2027 (USD Million)

Table 9 North America: Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)

Table 10 US: Superdisintegrants Market, by Type, 2020–2027 (USD Million)

Table 11 US: Superdisintegrants Market, by Formulation, 2020–2027 (USD Million)

Table 12 US: Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)

Table 13 Canada: Superdisintegrants Market, by Type, 2020–2027 (USD Million)

Table 14 Canada: Superdisintegrants Market, by Formulation, 2020–2027 (USD Million)

Table 15 Canada: Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)

Table 16 South America: Superdisintegrants Market, by Type, 2020–2027 (USD Million)

Table 17 South America: Superdisintegrants Market, by Formulation, 2020–2027 (USD Million)

Table 18 South America: Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)

Table 19 Europe: Superdisintegrants Market, by Type, 2020–2027 (USD Million)

Table 20 Europe: Superdisintegrants Market, by Formulation, 2020–2027 (USD Million)

Table 21 Europe: Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)

Table 22 Western Europe: Superdisintegrants Market, by Type, 2020–2027 (USD Million)

Table 23 Western Europe: Superdisintegrants Market, by Formulation, 2020–2027 (USD Million)

Table 24 Western Europe: Superdisintegrants Market, by Therapeutic Area, 2020–2027(USD Million)

Table 25 Eastern Europe: Superdisintegrants Market, by Type, 2020–2027 (USD Million)

Table 26 Eastern Europe: Superdisintegrants Market, by Formulation, 2020–2027 (USD Million)

Table 27 Eastern Europe: Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)

Table 28 Asia-Pacific: Superdisintegrants Market, by Type, 2020–2027 (USD Million)

Table 29 Asia-Pacific: Superdisintegrants Market, by Formulation, 2020–2027 (USD Million)

Table 30 Asia-Pacific: Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)

Table 31 Middle East & Africa: Superdisintegrants by Market, by Type, 2020–2027 (USD Million)

Table 32 Middle East & Africa: Superdisintegrants Market, by Formulation, 2020–2027 (USD Million)

Table 33 Middle East & Africa Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Superdisintegrants Market

Figure 3 Segmentation Market Dynamics for Global Superdisintegrants Market

Figure 4 Global Superdisintegrants Market Share, by Type, 2020

Figure 5 Global Superdisintegrants Market Share, by Formulation, 2020

Figure 6 Global Superdisintegrants Market Share, by Therapeutic Area, 2020

Figure 7 Global Superdisintegrants Market Share, by Region, 2020

Figure 8 North America: Superdisintegrants Market Share, by Country, 2020

Figure 9 Europe: Superdisintegrants Market Share, by Country, 2020

Figure 10 Asia-Pacific: Superdisintegrants Market Share, by Country, 2020

Figure 11 Middle East & Africa: Superdisintegrants Market Share, by Country, 2020

Figure 12 Global Superdisintegrants Market: Company Share Analysis, 2020 (%)

Figure 13 BASF SE: Key Financials

Figure 14 BASF SE: Segmental Revenue

Figure 15 BASF SE: Geographical Revenue

Figure 16 Ashland Global Holdings Inc.: Key Financials

Figure 17 Ashland Global Holdings Inc.: Segmental Revenue

Figure 18 Ashland Global Holdings Inc.: Geographical Revenue

Figure 19 DowDuPont Inc.: Key Financials

Figure 20 DowDuPont Inc.: Segmental Revenue

Figure 21 DowDuPont Inc.: Geographical Revenue

Figure 22 Roquette Freres: Key Financials

Figure 23 Roquette Freres: Segmental Revenue

Figure 24 Roquette Freres: Geographical Revenue

Figure 25 DFE Pharma: Key Financials

Figure 26 DFE Pharma: Segmental Revenue

Figure 27 DFE Pharma: Geographical Revenue

Figure 28 JRS Pharma: Key Financials

Figure 29 JRS Pharma: Segmental Revenue

Figure 30 JRS Pharma: Geographical Revenue

Figure 31 Asahi Kasei Corporation: Key Financials

Figure 32 Asahi Kasei Corporation: Segmental Revenue

Figure 33 Asahi Kasei Corporation: Geographical Revenue

Figure 34 Merck KGaA: Key Financials

Figure 35 Merck KGaA: Segmental Revenue

Figure 36 Merck KGaA: Geographical Revenue

Figure 37 Corel Pharma Chem: Key Financials

Figure 38 Corel Pharma Chem: Segmental Revenue

Figure 39 Corel Pharma Chem: Geographical Revenue

Figure 40 Avantor Performance Materials, LLC: Key Financials

Figure 41 Avantor Performance Materials, LLC: Segmental Revenue

Figure 42 Avantor Performance Materials, LLC: Geographical Revenue